Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Haemostatic markers are associated with measures of vascular disease in adults with hypertension

Journal of Human Hypertension volume 23, pages 530–537 (2009)Cite this article

Abstract

Haemostatic markers have been implicated in the development and progression of vascular disease. We investigated the associations of several haemostatic markers (fibrinogen, D-dimer, FV, FVII, FVIII, von Willebrand factor (vWF) and antithrombin III) with two quantitative measures of vascular disease in adults with hypertension. Participants included 1051 African Americans (65±9 years, 72% women) and 894 non-Hispanic whites (61±9 years, 55% women) belonging to hypertensive sibships. Phenotypes of vascular disease included the ankle–brachial index (ABI), a measure of peripheral arterial disease, and urinary albumin/creatinine ratio (UACR), a surrogate of glomerular endothelial function. Generalized estimating equations were used to assess whether plasma levels of haemostatic markers were associated with measures of arteriosclerosis, after adjustment for conventional risk factors and medication (statin, aspirin and oestrogen) use. Higher fibrinogen and D-dimer were significantly associated with lower ABI in African Americans (P<0.001 and 0.004 respectively) and in non-Hispanic whites (P<0.001 and 0.010 respectively). Higher fibrinogen (P<0.001), D-dimer (P=0.003), FVIII (P<0.001) and vWF (P<0.001) were significantly associated with higher UACR in African Americans, whereas, in non-Hispanic whites, higher fibrinogen (P=0.020) and FVII (P=0.006) were significantly associated with higher UACR. Our findings indicate that in adults with essential hypertension, several markers in the haemostatic pathway are independently associated with ABI and UACR, two measures of vascular disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Poli KA, Tofler GH, Larson MG, Evans JC, Sutherland PA, Lipinska I et al. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation 2000; 101: 264–269.

    Article  CAS  PubMed  Google Scholar 

  2. Wall U, Jern C, Bergbrant A, Jern S . Enhanced levels of tissue-type plasminogen activator in borderline hypertension. Hypertension 1995; 26: 796–800.

    Article  CAS  PubMed  Google Scholar 

  3. Lip GY, Blann AD . Does hypertension confer a prothrombotic state? Virchow's triad revisited. Circulation 2000; 101: 218–220.

    Article  CAS  PubMed  Google Scholar 

  4. Lee AJ . The role of rheological and haemostatic factors in hypertension. J Hum Hypertens 1997; 11: 767–776.

    Article  CAS  PubMed  Google Scholar 

  5. Cushman M, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M et al. Association of fibrinogen and coagulation factors Vii and Viii with cardiovascular risk factors in the elderly—the Cardiovascular Health Study. Am J Epidemiol 1996; 143: 665–676.

    Article  CAS  PubMed  Google Scholar 

  6. Blann AD, Naqvi T, Waite M, McCollum CN . von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993; 7: 107–111.

    CAS  PubMed  Google Scholar 

  7. Lemne C, De Faire U . Elevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbances. Eur J Clin Invest 1996; 26: 692–697.

    Article  CAS  PubMed  Google Scholar 

  8. Jansson JH, Johansson B, Boman K, Nilsson TK . Hypo-fibrinolysis in patients with hypertension and elevated cholesterol. J Int Med 1991; 229: 309–316.

    Article  CAS  Google Scholar 

  9. Boerwinkle E . Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP). Hypertension 2002; 39: 3–9.

    Article  Google Scholar 

  10. O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST . Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 2004; 164: 1313–1318.

    Article  PubMed  Google Scholar 

  11. von Clauss A . Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237–246.

    Article  Google Scholar 

  12. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT . Best reproducibility of the ankle-arm index was calculated using Doppler and dividing highest ankle pressure by highest arm pressure. J Clin Epidemiol 2005; 58: 1282–1288.

    Article  PubMed  Google Scholar 

  13. Hiatt WR . Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608–1621.

    Article  CAS  PubMed  Google Scholar 

  14. Magee L . R2 measures based on Wald and likelihood ratio joint significance tests. Am Stat 1990; 44: 250–253.

    Google Scholar 

  15. Zeger SL, Liang KY . Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121–130.

    Article  CAS  PubMed  Google Scholar 

  16. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ . Epidemiological characteristics of platelet aggregability. BMJ 1985; 290: 428–432.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lowe GD, Drummond MM, Lorimer AR, Hutton I, Forbes CD, Prentice CR et al. Relation between extent of coronary artery disease and blood viscosity. BMJ 1980; 280: 673–674.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Reinhart WH . Fibrinogen—marker or mediator of vascular disease? Vasc Med 2003; 8: 211–216.

    Article  PubMed  Google Scholar 

  19. Khawaja FJ, Bailey KR, Turner ST, Kardia SL, Mosley Jr TH, Kullo IJ . Association of novel risk factors with the ankle brachial index in African American and non-Hispanic white populations. Mayo Clin Proc 2007; 82: 709–716.

    Article  PubMed  Google Scholar 

  20. Selvin E, Erlinger TP . Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation 2004; 110: 738–743.

    Article  PubMed  Google Scholar 

  21. Mandl J, Csala M, Lerant I, Banhegyi G, Biro J, Machovich R et al. Enhancement of interleukin-6 production by fibrinogen degradation product D in human peripheral monocytes and perfused murine liver. Scand J Immunol 1995; 42: 175–178.

    Article  CAS  PubMed  Google Scholar 

  22. Reich LM, Heiss G, Boland LL, Hirsch AT, Wu K, Folsom AR . Ankle–brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort. Vasc Med 2007; 12: 267–273.

    Article  PubMed  Google Scholar 

  23. McDermott MM, Green D, Greenland P, Liu K, Criqui MH, Chan C et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003; 92: 194–199.

    Article  CAS  PubMed  Google Scholar 

  24. Sechi LA, Zingaro L, Catena C, Casaccio D, De Marchi S . Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension 2000; 36: 978–985.

    Article  CAS  PubMed  Google Scholar 

  25. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C et al. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the Cardiovascular Health Study. Am J Kidney Dis 2004; 44: 25–34.

    Article  PubMed  Google Scholar 

  26. Spiel AO, Gilbert JC, Jilma B . von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation 2008; 117: 1449–1459.

    Article  CAS  PubMed  Google Scholar 

  27. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14–18.

    Article  CAS  PubMed  Google Scholar 

  28. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol 1996; 16: 455–461.

    Article  CAS  PubMed  Google Scholar 

  29. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G . PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994; 43: 426–429.

    Article  CAS  PubMed  Google Scholar 

  30. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T . Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol 1995; 15: 1114–1120.

    Article  CAS  PubMed  Google Scholar 

  31. Flack JM, Ferdinand KC, Nasser SA . Epidemiology of hypertension and cardiovascular disease in African Americans. J Clin Hypertens (Greenwich) 2003; 5: 5–11.

    Article  Google Scholar 

  32. Tracy RP, Bovill EG, Fried LP, Heiss G, Lee MH, Polak JF et al. The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years. Results from the Cardiovascular Health Study. Ann Epidemiol 1992; 2: 509–519.

    Article  CAS  PubMed  Google Scholar 

  33. Allison MA, Criqui MH, McClelland RL, Scott JM, McDermott MM, Liu K et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006; 48: 1190–1197.

    Article  PubMed  Google Scholar 

  34. Tzoulaki I, Murray GD, Price JF, Smith FB, Lee AJ, Rumley A et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am J Epidemiol 2006; 163: 334–341.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants HL-81331 and HL-75794 from the National Institutes of Health.

Author information

Authors and Affiliations

  1. Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA

    M Khaleghi, L A Singletary, V Kondragunta & I J Kullo

  2. Division of Biostatistics, Mayo Clinic, Rochester, MN, USA

    K R Bailey

  3. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA

    S T Turner

  4. Department of Medicine (Geriatrics), University of Mississippi Medical Center, Jackson, MS, USA

    T H Mosley Jr

Authors
  1. M Khaleghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L A Singletary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V Kondragunta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K R Bailey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S T Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T H Mosley Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I J Kullo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I J Kullo.

Additional information

Conflict of interest

The authors have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khaleghi, M., Singletary, L., Kondragunta, V. et al. Haemostatic markers are associated with measures of vascular disease in adults with hypertension. J Hum Hypertens 23, 530–537 (2009). https://doi.org/10.1038/jhh.2008.170

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2008.170

Keywords

This article is cited by

Search

Advanced search

Quick links